BUDDYCONCEPT
  • Home
  • Current Affair
  • Andhra Current Affair
  • Telangana Current Affair
  • International Concept
  • Indian Polity Concept
  • Home
  • Current Affair
  • Andhra Current Affair
  • Telangana Current Affair
  • International Concept
  • Indian Polity Concept

Anti-COVID-19 drug  2-deoxy-D-glucose (2-DG) developed by DRDO in collaboration with Dr. Reddy’s Laboratories, Hyderabad

9/5/2021

0 Comments

 
Developed by                            : Institute of Nuclear Medicine and Allied Sciences (INMAS)

The Drugs Controller General of India (DCGI) has granted permission for emergency use of an anti-COVID-19 therapeutic application of the drug 2-deoxy-D-glucose (2-DG), developed by the Institute of Nuclear Medicine and Allied Sciences (INMAS), a lab of the Defence Research and Development Organisation (DRDO), in collaboration with Dr. Reddy’s Laboratories, Hyderabad. The drug comes in powder form in sachets and is taken orally by dissolving it in water. It accumulates in the virus infected cells and prevents their growth by stopping viral synthesis and energy production.
0 Comments



Leave a Reply.

    Archives

    July 2021
    May 2021
    April 2021
    March 2021
    February 2021
    January 2021

  • Home
  • Current Affair
  • Andhra Current Affair
  • Telangana Current Affair
  • International Concept
  • Indian Polity Concept